Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA First-Cycle ANDA Approvals Not Rising Along With Full Clearances
Jun 24 2019
•
By
Derrick Gingery
Why are first-cycle approvals not increasing when overall ANDA approvals are on pace for another annual record? • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Generics
More from Biosimilars & Generics